A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities.

Khorasani, Laila N; Bastani, Asal; Shen, Tammy; Kaur, Gurlovellen; Shah, Nilpa D; Juarez, Lucia; Heyman, Michelle; Grassian, Julie; Cho, An-Chuen; Hotez, Emily

Khorasani, Laila N; Bastani, Asal; Shen, Tammy; Kaur, Gurlovellen; Shah, Nilpa D; Juarez, Lucia; Heyman, Michelle; Grassian, Julie; Cho, An-Chuen; Hotez, Emily.

Afiliación

Khorasani LN; David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Bastani A; David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Shen T; David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Kaur G; David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Shah ND; David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Juarez L; David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Heyman M; Graduate School of Education, University of California, Riverside, CA 92521, USA.
Grassian J; David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Cho AC; David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Hotez E; David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

Vaccines (Basel) ; 11(5)2023 Apr 25.

Article en En | MEDLINE | ID: mdl-37242999

Palabras clave

COVID-19; intellectual and developmental disability; neurodivergent; thematic coding; vaccine hesitancy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Qualitative_research Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google